Search

everythinglearnresearchcommunity

for

Search:↓

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Vaccination is crucial for managing Covid-19 despite new virus strains.

The guideline provides recommendations for managing alopecia areata effectively.

Early recognition and treatment of Peripheral Arterial Disease is crucial to improve survival and health outcomes.

Alopecia areata patients have eye issues and need regular eye exams.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

New information suggests that metformin might help more women with PCOS and infertility, not just those with glucose issues.

People with severe and long-lasting alopecia areata often have low vitamin D levels, and treatments with vitamin D-like substances might help.

People with androgenetic alopecia are more likely to have metabolic syndrome.

The document is a detailed medical reference on skin and genetic disorders.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Diseases have a big social impact in Nordic countries, affecting healthcare decisions.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

Women with PCOS tend to be less optimistic than those without it.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.